Skip to main content

Table 2 Comparison of SF-12v2 score between patients with good and poor TTR

From: Time in therapeutic range, quality of life and treatment satisfaction of patients on long-term warfarin for non-valvular atrial fibrillation: a cross-sectional study

SF12v2 parameters Total score;
Mean ± SD;
95% CI
Without adjustment Adjusted for duration* Adjusted for education*
Good TTF Poor TTF p value Good TTF Poor TTF p value Good TTF Poor TTF p value
Mean ± SD;
95% CI
Mean ± SD;
95% CI
Mean ± SE;
95% CI
Mean ± SE;
95% CI
Mean ± SE;
95% CI
Mean ± SE;
95% CI
PCS 47.0 ± 9.0;
45.9–48.0
48.3 ± 8.7;
46.3–50.3
46.5 ± 9.1;
45.3–47.7
0.150 48.2 ± 1.1;
46.1–50.3
46.6 ± 0.6;
45.4–47.7
0.175 47.7 ± 1.1;
45.7–49.8
46.7 ± 0.6;
45.5–47.9
0.395
MCS 53.5 ± 9.6;
52.4–54.6
53.4 ± 8.6;
51.4–55.4
53.6 ± 9.7;
52.3–54.9
0.919 53.5 ± 1.1;
51.3–55.8
53.5 ± 0.6;
52.3–54.8
0.998 53.6 ± 1.1;
51.3–55.9
53.5 ± 0.6;
52.2–54.8
0.951
PF 47.0 ± 10.6;
45.8–48.2
48.0 ± 10.9;
45.5–50.6
46.7 ± 10.5;
45.3–48.1
0.358 47.9 ± 1.2;
45.5–50.4
46.7 ± 0.7;
45.3–48.1
0.399 47.4 ± 1.2;
45.0–49.9
46.9 ± 0.7;
45.5–48.3
0.704
RP 48.2 ± 9.6;
47.1–49.3
48.6 ± 8.8;
46.5–50.6
48.1 ± 9.9;
46.8–49.4
0.684 48.6 ± 1.1;
46.3–50.8
48.1 ± 0.6;
46.8–49.3
0.698 48.2 ± 1.1;
46.0–50.5
48.2 ± 0.6;
46.9–49.4
0.968
BP 49.6 ± 10.5;
48.5–50.8
51.1 ± 9.5;
48.8–53.3
49.2 ± 10.7;
47.8–50.6
0.184 51.0 ± 1.2;
48.6–53.4
49.2 ± 0.7;
47.8–50.6
0.207 50.5 ± 1.2;
48.0–52.9
49.4 ± 0.7;
48.0–50.7
0.446
GH 47.6 ± 9.7;
46.5–48.7
47.9 ± 9.5;
45.7–50.1
47.5 ± 9.8;
46.2–48.8
0.730 47.9 ± 1.2;
45.7–50.2
47.5 ± 0.7;
46.2–48.8
0.737 48.1 ± 1.2;
45.8–50.4
47.4 ± 0.7;
46.2–48.7
0.639
V 56.3 ± 11.3;
55.0–57.6
56.9 ± 11.5;
54.2–59.6
56.1 ± 11.3;
54.6–57.6
0.602 57.0 ± 1.3;
54.3–59.6
56.1 ± 0.8;
54.6–57.5
0.561 57.1 ± 1.3;
54.5–59.7
56.0 ± 0.8;
54.5–57.5
0.505
SF 49.0 ± 10.7;
47.8–50.2
51.5 ± 7.9;
49.7–53.4
48.2 ± 11.3;
46.7–49.6
0.019 51.9 ± 1.3;
49.2–54.2
48.1 ± 0.7;
46.7–49.5
0.014 51.0 ± 1.2;
48.5–53.4
48.3 ± 0.7;
47.0–49.7
0.069
RE 48.8 ± 10.7;
47.6–50.0
48.2 ± 10.7;
45.7–50.7
49.0 ± 10.7;
47.6–50.4
0.563 48.1 ± 1.3;
45.6–50.6
49.0 ± 0.7;
47.6–50.4
0.523 48.2 ± 1.2;
45.7–50.7
49.0 ± 0.7;
47.6–50.4
0.607
MH 53.8 ± 9.9;
52.7–55.0
53.4 ± 9.3;
51.2–55.5
54.0 ± 10.1;
52.7–55.3
0.634 53.5 ± 1.2;
51.2–55.8
54.0 ± 0.7;
52.7–55.3
0.714 53.4 ± 1.2;
51.1–55.7
54.0 ± 0.7;
52.7–55.3
0.661
  1. SF12v2 short form 12v2 health survey, SD standard deviation, 95% CI 95% confidence interval, PCS physical component summary, MCS mental component summary, PF physical functioning, RP role–physical, BP bodily pain, GH general health perceptions, V vitality, SF social functioning, RE role–emotional, MH mental health
  2. *Adjusted with ANCOVA test
  3. Figures in bold are statistically significant